RxDoctor Payments Data

Daniel Zeitler, MD

Otology & Neurotology · Seattle, WANPI 1154525012

Payments from drug & device makers

$1,576,612in general payments, 2019–2025

Across 343 payments — averaging $4596.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$829K
  • Med-el Corporation$727K
  • Advanced Bionics, LLC$16K
  • Stryker$3K
  • Oticon Medical, LLC$549
  • Grace Medical, Inc.$376
  • plus $323 from 2 others

What the payments were for

  • Consulting fees$200,39185%
  • Speaking & faculty fees$8,9504%
  • Travel & lodging$14,2486%
  • Food & beverage$12,1505%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Cochlear Americas160$829,126
Med-el Corporation76$727,226
Advanced Bionics, LLC66$16,158
Stryker32$2,853
Oticon Medical, LLC2$549
Grace Medical, Inc.3$376
Medtronic3$277
Merz Pharmaceuticals, LLC1$45

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Washingtonto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$64,700
Medicare patients
197
Services billed
340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin38$1,096
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort16$996
Oxycodone Hcl12$22

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Seattle

Where these figures come from

Is this you, or does something look wrong? →